Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol

International Journal of Gynecological Pathology
October 5, 2022
Cited by 29


Related Papers

No related papers found

Powered by citation graph analysis